189 related articles for article (PubMed ID: 8642281)
21. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines.
Iwasaki A; Stiernholm BJ; Chan AK; Berinstein NL; Barber BH
J Immunol; 1997 May; 158(10):4591-601. PubMed ID: 9144471
[TBL] [Abstract][Full Text] [Related]
22. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.
Billetta R; Filaci G; Zanetti M
Eur J Immunol; 1995 Mar; 25(3):776-83. PubMed ID: 7705408
[TBL] [Abstract][Full Text] [Related]
23. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
Uger RA; Barber BH
J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
[TBL] [Abstract][Full Text] [Related]
24. Purification of antigenic peptide from murine hepatoma cells recognized by Class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells.
Nakatsuka K; Sugiyama H; Nakagawa Y; Takahashi H
J Hepatol; 1999 Jun; 30(6):1119-29. PubMed ID: 10406192
[TBL] [Abstract][Full Text] [Related]
25. CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes.
Lazzaro S; Giovani C; Mangiavacchi S; Magini D; Maione D; Baudner B; Geall AJ; De Gregorio E; D'Oro U; Buonsanti C
Immunology; 2015 Oct; 146(2):312-26. PubMed ID: 26173587
[TBL] [Abstract][Full Text] [Related]
26. B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells.
Luo L; Chapoval AI; Flies DB; Zhu G; Hirano F; Wang S; Lau JS; Dong H; Tamada K; Flies AS; Liu Y; Chen L
J Immunol; 2004 Nov; 173(9):5445-50. PubMed ID: 15494491
[TBL] [Abstract][Full Text] [Related]
27. Generation of hen egg lysozyme-specific and major histocompatibility complex class I-restricted cytolytic T lymphocytes: recognition of cytosolic and secreted antigen expressed by transfected cells.
Forquet F; Calin V; Trescol-Biemont MC; Kanellopoulos J; Mottez E; Kourilsky P; Rabourdin-Combe C; Gerlier D
Eur J Immunol; 1990 Oct; 20(10):2325-32. PubMed ID: 2242761
[TBL] [Abstract][Full Text] [Related]
28. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.
Ramarathinam L; Castle M; Wu Y; Liu Y
J Exp Med; 1994 Apr; 179(4):1205-14. PubMed ID: 7511683
[TBL] [Abstract][Full Text] [Related]
29. Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells.
Dezfouli S; Hatzinisiriou I; Ralph SJ
Immunol Cell Biol; 2003 Dec; 81(6):459-71. PubMed ID: 14636243
[TBL] [Abstract][Full Text] [Related]
30. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells.
Cardoso AA; Seamon MJ; Afonso HM; Ghia P; Boussiotis VA; Freeman GJ; Gribben JG; Sallan SE; Nadler LM
Blood; 1997 Jul; 90(2):549-61. PubMed ID: 9226154
[TBL] [Abstract][Full Text] [Related]
32. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
Böhm W; Schirmbeck R; Elbe A; Melber K; Diminky D; Kraal G; van Rooijen N; Barenholz Y; Reimann J
J Immunol; 1995 Oct; 155(7):3313-21. PubMed ID: 7561024
[TBL] [Abstract][Full Text] [Related]
33. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.
Zhou X; Berglund P; Zhao H; Liljeström P; Jondal M
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3009-13. PubMed ID: 7708765
[TBL] [Abstract][Full Text] [Related]
34. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
Paglia P; Chiodoni C; Rodolfo M; Colombo MP
J Exp Med; 1996 Jan; 183(1):317-22. PubMed ID: 8551239
[TBL] [Abstract][Full Text] [Related]
35. Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes.
Arkema A; Huckriede A; Schoen P; Wilschut J; Daemen T
Vaccine; 2000 Jan; 18(14):1327-33. PubMed ID: 10618529
[TBL] [Abstract][Full Text] [Related]
36. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
[TBL] [Abstract][Full Text] [Related]
37. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells.
Ulmer JB; Deck RR; Dewitt CM; Donnhly JI; Liu MA
Immunology; 1996 Sep; 89(1):59-67. PubMed ID: 8911141
[TBL] [Abstract][Full Text] [Related]
38. Two mechanisms for tumor evasion of preexisting cytotoxic T-cell responses: lessons from recurrent tumors.
Zheng P; Sarma S; Guo Y; Liu Y
Cancer Res; 1999 Jul; 59(14):3461-7. PubMed ID: 10416611
[TBL] [Abstract][Full Text] [Related]
39. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.
Cole GA; Hogg TL; Coppola MA; Woodland DL
J Immunol; 1997 May; 158(9):4301-9. PubMed ID: 9126992
[TBL] [Abstract][Full Text] [Related]
40. Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells.
Fink PJ; Weissman IL; Bevan MJ
J Exp Med; 1983 Jan; 157(1):141-54. PubMed ID: 6217276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
